RetinalGenix Technologies (RTGN) Assets Average (2021 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Assets Average came in at $13423.0 in Q1 2026, little changed year-on-year from $13438.5 in Q1 2025, and down 4.27% quarter-over-quarter from $14021.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Assets Average (2021 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Assets Average across 6 years of filings, most recently posting $13423.0 for Q1 2026.
- Assets Average for Q1 2026 came in at $13423.0, changed 0.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $13423.0 (changed 0.12% YoY), and the FY2025 annual result was $17993.5, up 138.29% from the prior year.
- Assets Average came in at $13423.0 for Q1 2026 at RetinalGenix Technologies, down from $14021.0 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $87936.5 in Q3 2024 to a low of $190.5 in Q4 2023.
- The 5-year median for Assets Average is $7694.5 (2025), against an average of $18356.7.
- Across the five-year window, Assets Average surged 27144.09% in 2024 and slumped 91.25% in 2025, its largest moves.
- RetinalGenix Technologies' Assets Average stood at $2104.0 in 2022, then slumped by 90.95% to $190.5 in 2023, then soared by 27144.09% to $51900.0 in 2024, then slumped by 72.98% to $14021.0 in 2025, then decreased by 4.27% to $13423.0 in 2026.
- The last three Assets Average figures came in at $13423.0 (Q1 2026), $14021.0 (Q4 2025), and $7694.5 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.42 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.64 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.49 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.66 Bn |
| 10 | RetinalGenix Technologies | - | - | - | 13,423.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,423.00 |
| Dec 31, 2025 | 14,021.00 |
| Sep 30, 2025 | 7,694.50 |
| Jun 30, 2025 | 10,159.50 |
| Mar 31, 2025 | 13,438.50 |
| Dec 31, 2024 | 51,900.00 |
| Sep 30, 2024 | 87,936.50 |
| Jun 30, 2024 | 68,768.00 |
| Mar 31, 2024 | 25,336.50 |
| Dec 31, 2023 | 190.50 |
| Sep 30, 2023 | 1,172.00 |
| Jun 30, 2023 | 4,910.00 |
| Mar 31, 2023 | 3,997.50 |
| Dec 31, 2022 | 2,104.00 |
| Sep 30, 2022 | 1,970.50 |
| Jun 30, 2022 | 1,291.00 |
| Mar 31, 2022 | 3,751.00 |
| Dec 31, 2021 | 20,762.50 |